Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by tboron Jun 30, 2008 4:32pm

298 Views

Post# 15245692

RE: hope for RVX

You know Nobody you really are sad, now you are copying posts from other people. How sad can you get.

"There's only two kinds of hope

'Bob Hope' and 'no hope'.
Guess what they are both dead."

Above your post from today on this board.

And below is "basement1's" post June 25 on the BDO board

'There is only two kinds of hope.............Bob Hope and no hope.....and there both dead."

I see you also post on the BDO board, if you going to use someone else's quotes at least give them credit.

Or better yet try to have an original thought.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta